US FDA under fire after it forecasts work until June 2023 on final PMTA reviews

The US Food and Drug Administration (FDA) has published the first of its court-ordered regular updates on its premarket tobacco product application (PMTA) progress and it has not gone down well with health lobbyists.

The FDA said in its report that it would not finish reviewing the remaining PMTA applications until at least June 2023, a delay groups such as the Truth Initiative and the American Heart Association say will harm public health.

Read full article
I'm already a subscriber
Author default picture


This article was written by one of ECigIntelligence’s international correspondents. We currently employ more than 40 reporters around the world to cover individual vaping markets. For a full list, please see our Who We Are page.

Our Key Benefits

The global e-cigarette market is in an opaque regulatory environment that requires professionals to be on top of industry developments to make informed decisions and optimise their strategy.

ECigIntelligence provides organisations with leading market and regulatory data analysis to anticipate and understand market developments globally and the impact of regulatory changes to the business.

  • Stay informed of any legal and market change in the sector that impacts your organisation
  • Maximise resources by getting market and legal data analysis daily in one place
  • Make smart decisions by understanding how the regulatory and market landscape evolves
  • Anticipate risks in your decisions by monitoring regulatory changes that impact your organization